Advancing Cancer Therapy: Your Source for Palbociclib Intermediates

Discover the critical role of 6-Bromo-2-chloro-8-cyclopentyl-5-methylpyrido[2,3-d]pyrimidin-7(8H)-one in the synthesis of Palbociclib, a groundbreaking treatment for breast cancer. As a leading supplier in China, we provide high-purity intermediates essential for your pharmaceutical research and development needs.

Get a Quote & Sample

Advantages Provided by the Product

Enabling Novel Cancer Treatments

Leverage this essential pharmaceutical intermediate to advance research in CDK4 and CDK6 inhibitors, contributing to the development of next-generation cancer treatments.

Ensuring Synthesis Efficiency

The high purity of this compound ensures reproducible and efficient synthesis routes for complex pharmaceutical molecules, optimizing your R&D process.

Reliable Supply Chain

Benefit from a consistent and reliable supply of this critical intermediate, sourced from experienced manufacturers in China, ensuring uninterrupted production.

Key Applications

Oncology Drug Development

This intermediate is instrumental in the synthesis of Palbociclib, a vital drug for treating hormone receptor-positive, HER2-negative advanced or metastatic breast cancer.

CDK Inhibitor Research

Its chemical structure makes it an ideal precursor for synthesizing novel compounds targeting Cyclin-Dependent Kinases (CDKs) 4 and 6, crucial for cell cycle regulation.

Custom Synthesis Projects

We provide this high-quality intermediate for custom synthesis projects, supporting pharmaceutical companies in their specific drug discovery and development pathways.

API Manufacturing

Serve as a foundational component in the large-scale manufacturing of Active Pharmaceutical Ingredients (APIs) like Palbociclib, meeting industrial demand.